These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 34986639)
1. Anticancer Vaccination with Immunogenic Micelles That Capture and Release Pristine CD8 Ren H; Li J; Liu G; Sun Y; Yang X; Jiang Z; Zhang J; Lovell JF; Zhang Y ACS Appl Mater Interfaces; 2022 Jan; 14(2):2510-2521. PubMed ID: 34986639 [TBL] [Abstract][Full Text] [Related]
2. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma. Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169 [TBL] [Abstract][Full Text] [Related]
3. Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8 Xiang SD; Wilson KL; Goubier A; Heyerick A; Plebanski M Front Immunol; 2018; 9():2968. PubMed ID: 30631324 [TBL] [Abstract][Full Text] [Related]
4. Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy. Pedersen SR; Sørensen MR; Buus S; Christensen JP; Thomsen AR J Immunol; 2013 Oct; 191(7):3955-67. PubMed ID: 24018273 [TBL] [Abstract][Full Text] [Related]
5. Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model. Nguyen CT; Hong SH; Sin JI; Vu HV; Jeong K; Cho KO; Uematsu S; Akira S; Lee SE; Rhee JH Vaccine; 2013 Aug; 31(37):3879-87. PubMed ID: 23831323 [TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis. Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885 [TBL] [Abstract][Full Text] [Related]
7. CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors. Hanson HL; Kang SS; Norian LA; Matsui K; O'Mara LA; Allen PM J Immunol; 2004 Apr; 172(7):4215-24. PubMed ID: 15034034 [TBL] [Abstract][Full Text] [Related]
8. Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication. Maynard SK; Marshall JD; MacGill RS; Yu L; Cann JA; Cheng LI; McCarthy MP; Cayatte C; Robbins SH BMC Cancer; 2019 Jun; 19(1):540. PubMed ID: 31170937 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine. Valmori D; Dutoit V; Ayyoub M; Rimoldi D; Guillaume P; Liénard D; Lejeune F; Cerottini JC; Romero P; Speiser DE Cancer Immun; 2003 Oct; 3():15. PubMed ID: 14580186 [TBL] [Abstract][Full Text] [Related]
10. CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope. Cornet S; Menez-Jamet J; Lemonnier F; Kosmatopoulos K; Miconnet I Vaccine; 2006 Mar; 24(11):1880-8. PubMed ID: 16300869 [TBL] [Abstract][Full Text] [Related]
11. Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors. Sandoval F; Terme M; Nizard M; Badoual C; Bureau MF; Freyburger L; Clement O; Marcheteau E; Gey A; Fraisse G; Bouguin C; Merillon N; Dransart E; Tran T; Quintin-Colonna F; Autret G; Thiebaud M; Suleman M; Riffault S; Wu TC; Launay O; Danel C; Taieb J; Richardson J; Zitvogel L; Fridman WH; Johannes L; Tartour E Sci Transl Med; 2013 Feb; 5(172):172ra20. PubMed ID: 23408053 [TBL] [Abstract][Full Text] [Related]
12. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses. Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946 [TBL] [Abstract][Full Text] [Related]
13. Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy. Li H; Li Y; Wang X; Hou Y; Hong X; Gong T; Zhang Z; Sun X Theranostics; 2017; 7(18):4383-4398. PubMed ID: 29158834 [TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo. Yang Y; Che Y; Zhao Y; Wang X Int Immunopharmacol; 2019 Apr; 69():279-288. PubMed ID: 30743204 [TBL] [Abstract][Full Text] [Related]
15. Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy. Yang X; Yu T; Zeng Y; Lian K; Zhou X; Li S; Qiu G; Jin X; Yuan H; Hu F Carbohydr Polym; 2020 Jul; 240():116270. PubMed ID: 32475559 [TBL] [Abstract][Full Text] [Related]
16. Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses. Kumai T; Lee S; Cho HI; Sultan H; Kobayashi H; Harabuchi Y; Celis E Cancer Immunol Res; 2017 Jan; 5(1):72-83. PubMed ID: 27941004 [TBL] [Abstract][Full Text] [Related]
17. Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination. Rad-Malekshahi M; Fransen MF; Krawczyk M; Mansourian M; Bourajjaj M; Chen J; Ossendorp F; Hennink WE; Mastrobattista E; Amidi M Mol Pharm; 2017 May; 14(5):1482-1493. PubMed ID: 28088862 [TBL] [Abstract][Full Text] [Related]
18. Targeting cryptic epitope with modified antigen coupled to the surface of liposomes induces strong antitumor CD8 T-cell immune responses in vivo. Horiuchi Y; Takagi A; Uchida T; Akatsuka T Oncol Rep; 2015 Dec; 34(6):2827-36. PubMed ID: 26398429 [TBL] [Abstract][Full Text] [Related]
19. Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging. Kadayakkara DK; Korrer MJ; Bulte JW; Levitsky HI Cancer Res; 2015 Jan; 75(1):51-61. PubMed ID: 25388285 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand. Hung CF; Hsu KF; Cheng WF; Chai CY; He L; Ling M; Wu TC Cancer Res; 2001 Feb; 61(3):1080-8. PubMed ID: 11221836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]